Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD)
Terushige Muraoka(Chugai Pharma (United States)), Mitsuaki Ide, Kenji Morikami, Machiko Irie, Mitsuaki Nakamura, Takaaki Miura, Takayuki Kamikawa, Masamichi Nishihara, Hirotaka Kashiwagi
Cited by 15Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis